Natural and man-made V-gene repertoires for antibody discovery

Frontiers in Immunology

Volumn 3, Issue NOV, 2012, Pages

  Finlay, William J J ^a   Almagro, Juan C ^a  

^a PFIZER INC   (United States)

Author keywords

Antibody structure; Antigen binding site; Structure function relationship; Therapeutic antibodies

Indexed keywords

EID: 84874213990     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00342     Document Type: Review

References (186)

1. Abhinandan, K. R., and Martin, A. C. (2010). Analysis and prediction of VH/VL packing in antibodies. Protein Eng Des. Sel. 23, 689-697.
2. Aitken, R., Gilchrist, J., and Sinclair, M. C. (1997). A single diversified VH gene family dominates the bovine immunoglobulin repertoire. Biochem. Soc. Trans. 25, 326S.
3. Al-Lazikani, B., Lesk, A. M., and Chothia, C. (1997). Standard conformations for the canonical structures of immunoglobulins. J. Mol. Biol. 273, 927-948.
4. Almagro, J. C. (2004). Identification of differences in the specificity-determining residues of antibodies that recognize antigens of different size: implications for the rational design of antibody repertoires. J. Mol. Recognit. 17, 132-143.
5. Almagro, J. C., Beavers, M., Hernandez-Guzman, F., Maier, J., Shaulsky, J., Butenhof, K., et al. (2011). Antibody modeling assessment. Proteins 79, 3050-3066.
6. Almagro, J. C., and Fransson, J. (2008). Humanization of antibodies. Front. Biosci. 13, 1619-1633.
7. Almagro, J. C., Hernandez I., del Carmen Ramirez, M., and Vargas-Madrazo, E. (1997). The differences between the structural repertoires of IGHV germ-line gene segments of mice and humans: implication for the molecular mechanism of the immune response. Mol. Immunol. 34, 1199-1214.
8. Almagro, J. C., Raghunathan, G., Beil, E., Janecki, D. J., Chen, Q., Dinh, T., et al. (2012). Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain. J. Mol. Recognit. 25, 125-135.
9. Alt, F., and Baltimore, D. (1982). Joining of immunoglobulin heavy chain gene segments: implications from a chromosome with evidence of three D-JH fusions. Proc. Natl. Acad. Sci. U.S.A. 79, 4118-4122.
10. Amzel, L. M., and Poljak, R. J. (1979). Three-dimensional structure of immunoglobulins. Annu. Rev. Biochem. 48, 961-997.
11. Barbas, C. E 3rd., Amberg, W., Simoncsits, A., Jones, T. M., and Lerner, R. A. (1993). Selection of human anti-hapten antibodies from semisynthetic libraries. Gene 137, 57-62.
12. Barbas, C. E 3rd., Bain, J. D., Hoekstra, D. M., and Lerner, R. A. (1992). Semisynthetic combinatorial antibody libraries: a chemical solution to the diversity problem. Proc. Natl. Acad. Sci. U.S.A. 89, 4457-4461.
13. Barthelemy, P. A., Raab, H., Appleton, B. A., Bond, C. J., Wu, P., Wiesmann, C., et al. (2008). Comprehensive analysis of the factors contributing to the stability and solubility of autonomous human VH domains. J. Biol. Chem. 283, 3639-3654.
14. Benichou, J., Ben-Hamo, R., Louzoun, Y., and Efroni, S. (2012). Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology 135, 183-191.
15. Betz, A. G., Rada, C., Pannell, R., Milstein, C., and Neuberger, M. S. (1993). Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots. Proc. Natl. Acad. Sci. U.S.A. 90, 2385-2388.
16. Birtalan, S., Fisher, R. D., and Sidhu ,S.S. (2010). The functional capacity of the natural amino acids for molecular recognition. Mol. Biosyst. 6 1186-1194.
17. Birtalan, S., Zhang, Y., Fellouse, E A., Shao, L., Schaefer, G., and Sidhu, S. S. (2008). The intrinsic contributions of tyrosine, serine, glycine and arginine to the affinity and specificity of antibodies. J. Mol. Biol. 377, 1518-1528.
18. Bono, B. D., Madera, M., and Chothia, C. (2004). VH gene segments in the mouse and human genomes. J. Mol. Biol. 342, 131-143.
19. Borsi, L., Castellani, P., Allemanni, G., Neri, D., and Zardi, L. (1998). Preparation of phage antibodies to the ED-A domain of human fibronectin. Exp. Cell Res. 240, 244-251.
20. Boswell, C. A., Tesar, D. B., Mukhyala, K., Theil, E P., Fielder, P. J., and Khawli, L. A. (2010). Effects of charge on antibody tissue distribution and pharmacoki-netics. Bioconjug. Chem. 21, 2153-2163.
21. Brack, S. S., Silacci, M., Birchler, M., and Neri, D. (2006). Tumor-targeting properties of novel antibodies specific to the large isoform of tenascin-C. Clin. Cancer Res. 12, 3200-3208.
22. Bradbury, A. R. (2010). The use of phage display in neurobiology. Curr. Protoc. Neurosci. Chapter 5, Unit 5. 12.
23. Braunagel, M., and Little, M. (1997). Construction of a semisynthetic antibody library using trinucleotide oligos. Nucleic Acids Res. 25, 4690-4691.
24. Breden, F., Lepik, C., Longo, N., Montero, M., Lipsky, P., and Scott, J. (2011). Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease. PLoS ONE 6:e16857. doi: 10.1371/journal. pone.0016857
25. Brezinschek, H. P., Foster, S. J., Dorner, T., Brezinschek, R. I., and Lipsky, P. E. (1998). Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. J. Immunol. 160, 4762-4767.
26. Carnemolla, B., Neri, D., Castellani, P., Leprini, A., Neri, G., Pini, A., et al. (1996). Phage antibodies with pan-species recognition of the oncofoetal angiogenesis marker fibronectin ED-B domain. Int. I Cancer 68, 397-405.
27. Chailyan, A., Marcatili, P., Cirillo, D., and Tramontano, A. (2011). Structural repertoire of immunoglobulin λ light chains. Proteins 79, 1513-1524.
28. Chothia, C., and Lesk, A. M. (1987). Canonical structures for the hyper-variable regions of immunoglobulins. J. Mol. Biol. 196,901-917.
29. Chothia, C., Lesk, A. M., Gherardi, E., Tomlinson, I. M., Walter, G., Marks, J. D., et al. (1992). Structural repertoire of the human VH segments. I Mol. Biol. 227,799-817.
30. Chothia, C., Lesk, A. M., Tramontano, A., Levitt, M., Smith-Gill, S. J., Air, G., et al. (1989). Conformations of immunoglobulin hypervariable regions. Nature 342, 877-883.
31. Clark, L. A., Ganesan, S., Papp, S., and Vlijmen, H. W. V (2006). Trends in antibody sequence changes during the somatic hypermutation process. J. Immunol. 177, 333-340.
32. Cobaugh, C., Almagro, J., Pogson, M., Iverson, B., and Georgiou, G. (2008). Synthetic antibody libraries focused towards peptide ligands. J. Mol. Biol. 378, 622-633.
33. Connolly, M. L. (1983). Solvent-accessible surfaces of proteins and nucleic acids. Science 221, 709-713.
34. Cox, J. P., Tomlinson, I. M., and Winter, G. (1994). A directory of human germ-line V kappa segments reveals a strong bias in their usage. Eur. I Immunol. 24, 827-836.
35. Dal-Bo, M., Giudice, I. D., Bomben, R., Capello, D., Bertoni, F., Forconi, F., et al. (2011). B-cell receptor, clini-cal course and prognosis in chronic lymphocytic leukaemia: the grow-ing saga of the IGHV3 subgroup gene usage. Br. J. Haematol. 153, 3-14.
36. Davies, D. R., and Metzger, H. (1983). Structural basis of antibody function. Annu. Rev. Immunol. 1, 87-117.
37. Davies, J., and Riechmann, L. (1994). 'Camelising' human antibody fragments: NMR studies on VH domains. FEBS Lett. 339, 285-290.
38. De Genst, E., Saerens, D., Muyldermans, S., and Conrath, K. (2006). Antibody repertoire development in camelids. Dev. Comp. Immunol. 30, 187-198.
39. De Genst, E., Silence, K., Decanniere, K., Conrath, K., Loris, R., Kinne, J., et al. (2006). Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc. Natl. Acad Sci. U.S.A. 103, 4586-4591.
40. De Wildt, R. M., Hoet, R. M., van Venrooij, W. J., Tomlinson, I. M., and Winter, G. (1999). Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J. Mol. Biol. 285, 895-901.
41. Dooley, H., Flajnik, M. F., and Porter, A. J. (2003). Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display. Mol. Immunol. 40, 25-33.
42. Dörner, T., Foster, S. J., Farner, N. L., and Lipsky, P. E. (1998). Somatic hypermutation of human immunoglobulin heavy chain genes: targeting of RGYW motifs on both DNA strands. Eur. J. Immunol. 28, 3384-3396.
43. Ewert, S., Cambillau, C., Conrath, K., and Pluckthun, A. (2002). Biophysical properties of camelid V (HH) domains compared to those of human V (H)3 domains. Biochemistry 41, 3628-3636.
44. Ewert, S., Honegger, A., and Pluckthun, A. (2004). Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering. Methods 34, 184-199.
45. Ewert, S., Huber, T., Honegger, A., and Pluckthun, A. (2003). Biophysical properties of human antibody variable domains. J. Mol. Biol. 325, 531-553.
46. Farner, N. L., Dorner, T., and Lipsky, P. E. (1999). Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire. J. Immunol. 162, 2137-2145.
47. Fellouse, E A., Barthelemy, P. A., Kelley, R. F., and Sidhu, S. S. (2006). Tyrosine plays a dominant functional role in the paratope of a synthetic antibody derived from a four amino acid code. J. Mol. Biol. 357, 100-114.
48. Fellouse, E A., Esaki, K., Birtalan, S., Raptis, D., Cancasci, V. J., Koide, A., et al. (2007). High-throughput generation of synthetic antibodies from highly functional minimalist phage-displayed libraries. J. Mol. Biol. 373, 924-940.
49. Fellouse, E A., Li, B., Compaan, D. M., Peden, A. A., Hymowitz, S. G., and Sidhu, S. S. (2005). Molecular recognition by a binary code. J. Mol. Biol. 348, 1153-1162.
50. Fellouse, F. A., Wiesmann, C., and Sidhu, S. S. (2004). Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition. Proc. Natl. Acad. Sci. U.S.A. 101, 12467-12472.
51. Fennell, B. J., Darmanin-Sheehan, A., Hufton, S. E., Calabro, V., Wu, L., Muller, M. R., et al. (2010). Dissection of the IgNAR V domain: molecular scanning and ortho-logue database mining define novel IgNAR hallmarks and affinity maturation mechanisms. J. Mol. Biol. 400, 155-170.
52. Finlay, W. J., deVore, N. C., Dobrovolskaia, E. N., Gam, A., Goodyear, C. S., and Slater, J. E. (2005). Exploiting the avian immunoglobulin system to simplify the generation of recombinant antibodies to allergenic proteins. Clin. Exp. Allergy 35, 1040-1048.
53. Finlay, W. J., Shaw, I., Reilly, J. P., and Kane, M. (2006). Generation of high-affinity chicken single-chain Fv antibody fragments for measurement of the Pseudonitzschia pungens toxin domoic acid. Appl. Environ. Microbiol. 72, 3343-3349.
54. Fischer, N. (2011). Sequencing antibody repertoires: the next generation. MAbs 3, 17-20.
55. Fisher, R. D., Ultsch, M., Lingel, A., Schaefer, G., Shao, L., Birtalan, S., et al. (2010). Structure of the complex between HER2 and an antibody paratope formed by side chains from tryptophan and serine. J. Mol. Biol. 402,217-229.
56. Flajnik, M. F., Deschacht, N., and Muyldermans, S. (2011). A case of convergence: why did a simple alternative to canonical antibodies arise in sharks and camels? PLoS Biol. 9:e1001120. doi: 10.1371/ journal.pbio.1001120
57. Flajnik, M. F., and Dooley, H. (2009). The generation and selection of single-domain, v region libraries from nurse sharks. Methods Mol. Biol. 562, 71-82.
58. Foote, J., and Winter, G. (1992). Antibody framework residues affecting the conformation of the hypervariable loops. J. Mol. Biol. 224, 487-499.
59. Gill, D. S., and Damle, N. K. (2006). Biopharmaceutical drug discovery using novel protein scaffolds. Curr. Opin. Biotechnol. 17, 653-658.
60. Gilliland, G., Luo, J., Vafa, O., and Almagro, J. (2012). Leveraging SBDD in protein therapeutic development: antibody engineering. MethodsMol. Biol. 841, 321-349.
61. Glanville, J., Zhai, W., Berka, J., Telman, D., Huerta, G., Mehta, G. R., et al. (2009). Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire. Proc. Natl. Acad. Sci. U.S.A. 106, 20216-20221.
62. Govaert, J., Pellis, M., Deschacht, N., Vincke, C., Conrath, K., Muyldermans, S., et al. (2012). Dual beneficial effect of interloop disulfide bond for single domain antibody fragments. J. Biol. Chem. 287, 1970-1979.
63. Griffiths, A. D., Malmqvist, M., Marks, J. D., Bye, J. M., Embleton, M. J., McCafferty, J., et al. (1993). Human anti-self antibodies with high specificity from phage display libraries. EMBOJ. 12,725-734.
64. Griffiths, A. D., Williams, S. C., Hartley, O., Tomlinson, I. M., Waterhouse, P., Crosby, W. L., et al. (1994). Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13, 3245-3260.
65. Hackel, B. J., Ackerman, M. E., Howland, S. W., and Wittrup, K. D. (2010). Stability and CDR composition biases enrich binder functionality landscapes. J. Mol. Biol. 401, 84-96.
66. Hackel, B. J., and Wittrup, K. D. (2010). The full amino acid repertoire is superior to serine/tyrosine for selection of high affinity immunoglobulin G binders from the fibronectin scaffold. Protein Eng. Des. Sel. 23, 211-219.
67. Hamers-Casterman, C., Atarhouch, T., Muyldermans, S., Robinson, G., Hamers, C., Songa, E. B., et al. (1993). Naturally occurring antibodies devoid of light chains. Nature 363, 446-448.
68. Harding, E A., Stickler, M. M., Razo, J., and Dubridge, R. B. (2010). The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions. MAbs 2, 256-265.
69. Harmsen, M. M., and De Haard, H. J. (2007). Properties, production, and applications of camelid single-domain antibody fragments. Appl. Microbiol. Biotechnol. 77, 13-22.
70. Harmsen, M. M., Ruuls, R. C., Nijman, I. J., Niewold, T. A., Frenken, L. G., and de Geus, B. (2000). Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features. Mol. Immunol. 37, 579-590.
71. Hoogenboom, H. R. (2005). Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116.
72. Huang, S. C., Jiang, R., Glas, A. M., and Milner, E. C. (1996). Non-stochastic utilization of Ig V region genes in unselected human peripheral B cells. Mol. Immunol. 33, 553-560.
73. Ignatovich, O., Tomlinson, I. M., Jones, P. T., and Winter, G. (1997). The creation of diversity in the human immunoglobulin V (lambda) repertoire. J. Mol. Biol. 268, 69-77.
74. Jarutat, T., Frisch, C., Nickels, C., Merz, H., and Knappik, A. (2006). Isolation and comparative characterization of Ki-67 equivalent antibodies from the HuCAL phage display library. Biol. Chem. 387, 995-1003.
75. Jarutat, T., Nickels, C., Frisch, C., Stellmacher, F., Hofig, K. P., Knappik, A., et al. (2007). Selection of vimentin-specific antibodies from the HuCAL phage display library by subtractive panning on formalin-fixed, paraffin-embedded tissue. Biol. Chem. 388, 651-658.
76. Jiang, N., Weinstein, J., Penland, L., White, R. R., Fisher, D., and Quake, S. R. (2011). Determinism and stochasticity during maturation of the zebrafish antibody repertoire. Proc. Natl. Acad. Sci. U.S.A. 108, 5348-5353.
77. Johansson, J., Aveskogh, M., Munday, B., and Hellman, L. (2002). Heavy chain V region diversity in the duckbilled platypus (Ornithorhynchus anatinus): long and highly variable complementarity-determining region 3 compensates for limited germline diversity.J. Immunol. 168, 5155-5162.
78. Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., and Winter, G. (1986). Replacing the complementarity-determining regions in a human antibody with those from a mouse. Nature 321, 522-525.
79. Kabat, E. A., and Wu, T. T. (1971). Attempts to locate complementarity-determining residues in the variable positions of light and heavy chains. Ann. N.Y. Acad. Sci. 190,382-393.
80. Knappik, A., Ge, L., Honegger, A., Pack, P., Fischer, M., Wellnhofer, G., et al. (2000). Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. J. Mol. Biol. 296, 57-86.
81. Köhler, G., and Milstein, C. (1975). Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497.
82. Koide, S., and Sidhu, S. S. (2009). The importance of being tyrosine: lessons in molecular recognition from minimalist synthetic binding proteins. ACS Chem. Biol. 4, 325-334.
83. Kuroda, D., Shirai, H., Jacobson, M., and Nakamura, H. (2012). Computer-aided antibody design. Protein Eng. Des. Sel. 25, 507-522.
84. Lee, C. V., Hymowitz, S. G., Wallweber, H. J., Gordon, N. C., Billeci, K. L., Tsai, S. P., et al. (2006). Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cells. Blood 108,3103-3111.
85. Lee, C. V., Liang, W. C., Dennis, M. S., Eigenbrot, C., Sidhu, S. S., and Fuh, G. (2004). High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. J. Mol. Biol. 340,1073-1093.
86. Lefranc, M. P., Giudicelli, V., Kaas, Q., Duprat, E., Jabado-Michaloud, J., Scaviner, D., et al. (2005). IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33, D593-D597.
87. Lerner, R. (2011). Rare antibodies from combinatorial libraries suggests an S.O.S. component of the human immunological repertoire. Mol. Biosyst. 7, 1004-1012.
88. Li, F., and Aitken, R. (2004). Cloning of porcine scFv antibodies by phage display and expression in Escherichia coli. Vet. Immunol. Immunopathol. 97, 39-51.
89. Li, H., Jiang, Y., Prak, E. L., Radic, M., and Weigert, M. (2001). Editors and editing of anti-DNA receptors. Immunity 15, 947-957.
90. Lo Conte, L. L., Chothia, C., and Janin, J. (1999). The atomic structure of protein-protein recognition sites.J. Mol. Biol. 285, 2177-2198.
91. MacCallum, R., Martin, A., and Thornton, J. (1996). Antibody-antigen interactions: contact analysis and binding site topography. J. Mol. Biol. 262, 732-745.
92. Maizels, N. (2005). Immunoglobulin gene diversification. Annu. Rev. Genet. 39, 23-46.
93. Marget, M., Sharma, B. B., Tesar, M., Kretzschmar, T., Jenisch, S., Westphal, E., et al. (2000). Bypassing hybridoma technology: HLA-C reactive human single-chain antibody fragments (scFv) derived from a synthetic phage display library (HuCAL) and their potential to discriminate HLA class I specificities. Tissue Antigens 56, 1-9.
94. Marks, J., Hoogenboom, H., Bonnert, T., McCafferty, J., Griffiths, A., and Winter, G. (1991). By-passing immunization. Human antibodies from V-gene libraries displayed on phage.J. Mol. Biol. 222, 581-597.
95. Martin, A. C., and Thornton, J. M. (1996). Structural families in loops of homologous proteins: automatic classification, modelling and application to antibodies. J. Mol. Biol. 263,800-815.
96. Martinez-Jean, C., Folch, G., and Lefranc, M. (2001). Nomenclature and overview of the mouse (Mus musculus and Mus sp.) immunoglobulin kappa (IGK) genes. Exp. Clin. Immunogenet. 18, 255-279.
97. Matsuda, F., Ishii, K., Bourvagnet, P., Kuma, K., Hayashida, H., Miyata, T., and Honjo, T. (1998). The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus. J. Exp. Med. 188, 2151-2162.
98. McCafferty, J., Griffiths, A. D., Winter, G., and Chiswell, D. J. (1990). Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348, 552-554.
99. Mian, I., Bradwell, A., and Olson, A. (1991). Structure, function and properties of antibody binding sites. I Mol. Biol. 217, 133-151.
100. Morea, V., Tramontano, A., Rustici, M., Chothia, C., and Lesk, A. M. (1998). Conformations of the third hyper-variable region in the VH domain of immunoglobulins. J. Mol. Biol. 275, 269-294.
101. Morrison, S. L., Johnson, M. J., Herzenberg, L. A., and Oi, V. T. (1984). Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc. Natl. Acad. Sci. U.S.A. 81,6851-6855.
102. Muyldermans, S., Baral, T. N., Retamozzo, V. C., De Baetselier, P., De Genst, E., Kinne, J., et al. (2009). Camelid immunoglobulins and nanobody technology. Vet. Immunol. Immunopathol. 128, 178-183.
103. Muyldermans, S., and Lauwereys, M. (1999). Unique single-domain antigen binding fragments derived from naturally occurring camel heavy-chain antibodies. J. Mol. Recognit. 12, 131-140.
104. Nelson, A., Dhimolea, E., and Reichert, J. (2010). Development trends for human monoclonal antibody therapeutics. Nat. Rev. Drug Discov. 9, 767-774.
105. Neri, D., Petrul, H., and Roncucci, G. (1995). Engineering recombi-nant antibodies for immunother-apy. Cell Biophys. 27, 47-61.
106. Neri, D., Pini, A., and Nissim, A. (1998). Antibodies from phage display libraries as immunochemical reagents. Methods Mol. Biol. 80, 475-500.
107. Neuberger, M. S., and Milstein, C. (1995). Somatic hypermutation. Curr. Opin. Immunol. 7, 248-254.
108. Nguyen, V. K., Desmyter, A., and Muyldermans, S. (2001). Functional heavy-chain antibodies in Camelidae. Adv. Immunol. 79, 261-296.
109. Nguyen, V. K., Hamers, R., Wyns, L., and Muyldermans, S. (1999). Loss of splice consensus signal is responsible for the removal of the entire C (H)1 domain of the functional camel IGG2A heavy-chain antibodies. Mol. Immunol. 36, 515-524.
110. Nguyen, V. K., Su, C., Muyldermans, S., and van der Loo, W. (2002). Heavy-chain antibodies in Camelidae; a case of evolutionary innovation. Immunogenetics 54, 39-47.
111. Nishibori, N., Horiuchi, H., Furusawa, S., and Matsuda, H. (2006). Humanization of chicken monoclonal antibody using phage-display system. Mol. Immunol. 43, 634-642.
112. Noia, J. D., and Neuberger, M. (2007). Molecular mechanisms of antibody somatic hypermutation. Annu. Rev. Biochem. 76, 1-22.
113. North, B., Lehmann, A., and Dunbrack, R. J. (2011). A new clustering of antibody CDR loop conformations. J. Mol. Biol. 406, 228-256.
114. O'Brien, P. M., Aitken, R., O'Neil, B. W., and Campo, M. S. (1999). Generation of native bovine mAbs by phage display. Proc. Natl. Acad. Sci. U.S.A. 96, 640-645.
115. Ohara, R., Knappik, A., Shimada, K., Frisch, C., Ylera, F., and Koga, H. (2006). Antibodies for proteomic research: comparison of traditional immunization with recombinant antibody technology. Proteomics 6, 2638-2646.
116. Padlan, E. A. (1977). Structural basis for the specificity of antibody-antigen reactions and structural mechanisms for the diversification of antigen-binding specificities. Q. Rev. Biophys. 10, 35-65.
117. Padlan, E. A. (1994). Anatomy of the antibody molecule. Mol. Immunol. 31, 169-217.
118. Parvari, R., Avivi, A., Lentner, F., Ziv, E., Tel-Or, S., Burstein, Y., et al. (1988). Chicken immunoglobulin gamma-heavy chains: limited VH gene repertoire, combinatorial diversification by D gene segments and evolution of the heavy chain locus. EMBOJ. 7, 739-744.
119. Parvari, R., Ziv, E., Lantner, F., Heller, D., and Schechter, I. (1990). Somatic diversification of chicken immunoglobulin light chains by point mutations. Proc. Natl. Acad. Sci. U.S.A. 87, 3072-3076.
120. Parvari, R., Ziv, E., Lantner, F., Tel-Or, S., Burstein, Y., and Schechter, I. (1987a). A few germline genes encode the variable regions of chicken immunoglobulin light and gamma-heavy chains. Prog. Clin. Biol. Res. 238, 15-26.
121. Parvari, R., Ziv, E., Lentner, F., Tel-Or, S., Burstein, Y., and Schechter, I. (1987b). Analyses of chicken immunoglobulin light chain cDNA clones indicate a few germline V lambda genes and allotypes of the C lambda locus. EMBO J. 6, 97-102.
122. Persson, H., Lantto, J., and Ohlin, M. (2006). A focused antibody library for improved hapten recognition. J. Mol. Biol. 357, 607-620.
123. Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., et al. (1998). Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J. Biol. Chem. 273, 21769-21776.
124. Prassler, J., Steidl, S., and Urlinger, S. (2009). In vitro affinity maturation of HuCAL antibodies: complementarity determining region exchange and RapMAT technology. Immunotherapy 1, 571-583.
125. Prassler, J., Thiel, S., Pracht, C., Polzer, A., Peters, S., Bauer, M., et al. (2011). HuCAL PLATINUM, a synthetic Fab library optimized for sequence diversity and superior performance in mammalian expression systems. J. Mol. Biol. 413, 261-278.
126. Raaphorst, F. M., Raman, C. S., Nall, B. T., and Teale, J. M. (1997). Molecular mechanisms governing reading frame choice of immunoglobulin diversity genes. Immunol. Today 18, 37-43.
127. Rada, C., Ehrenstein, M. R., Neuberger, M. S., and Milstein, C. (1998). Hot spot focusing of somatic hyper-mutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity 9, 135-141.
128. Rader, C., Ritter, G., Nathan, S., Elia, M., Gout, I., Jungbluth, A. A., et al. (2000). The rabbit antibody repertoire as a novel source for the generation of therapeutic human antibodies. J. Biol Chem. 275,13668-13676.
129. Ragunathan, G., Smart, J., Williams, J., and Almagro, J. (2012). Antigen-binding site anatomy and somaticmutations in antibodies that recognize different types of antigens. J. Mol. Recognit. 25, 103-113.
130. Rajewsky, K., Förster, I., and Cumano, A. (1987). Evolutionary and somatic selection of the antibody repertoire in the mouse. Science 238, 1088-1094.
131. Ramirez-Benitez, M. C., and Almagro, J. C. (2001). Analysis of antibodies of known structure suggests a lack of correspondence between the residues in contact with the antigen and those modified by somatic hypermutation. Proteins 45, 199-206.
132. Ratcliffe, M. J. (2006). Antibodies, immunoglobulin genes and the bursa of Fabricius in chicken B cell development. Dev. Comp. Immunol. 30, 101-118.
133. Reichert, J. (2012). Marketed therapeutic antibodies compendium. MAbs 4,413-415.
134. Reynaud, C. A., Anquez, V., Dahan, A., and Weill, J. C. (1985). A single rearrangement event generates most of the chicken immunoglobulin light chain diversity. Cell 40, 283-291.
135. Reynaud, C. A., Anquez, V., Grimal, H., and Weill, J. C. (1987). A hyperconversion mechanism generates the chicken light chain preim-mune repertoire. Cell 48, 379-388.
136. Reynaud, C. A., Anquez, V., and Weill, J. C. (1991). The chicken D locus and its contribution to the immunoglobulin heavy chain repertoire. Eur. J. Immunol. 21, 2661-2670.
137. Reynaud, C. A., Dahan, A., Anquez, V., and Weill, J. C. (1989). Somatic hyperconversion diversifies the single Vh gene of the chicken with a high incidence in the D region. Cell 59, 171-183.
138. Reynaud, C. A., Dahan, A., and Weill, J. C. (1983). Complete sequence of a chicken lambda light chain immunoglobulin derived from the nucleotide sequence of its mRNA. Proc. Natl. Acad. Sci. U.S.A. 80, 4099-4103.
139. Riechmann, L., and Muyldermans, S. (1999). Single domain antibodies: comparison of camel VH and camelised human VH domains. J.Immunol. Methods 231, 25-38.
140. Rothe, C., Urlinger, S., Lohning, C., Prassler, J., Stark, Y., Jager, U., et al. (2008). The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. J. Mol. Biol. 376, 1182-1200.
141. Sanz, I. (1991). Multiple mechanisms participate in the generation of diversity of human H chain CDR3 regions. J. Immunol. 147, 1720-1729.
142. Saphire, E., Parren, P., Pantophlet, R., Zwick, M., Morris, G., Rudd, P., et al. (2001). Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. Science 293, 1155-1159.
143. Schäble, K., Thiebe, R., Bensch, A., Brensing-Küppers, J., Heim, V., Kirschbaum, T., et al. (1999). Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome. Eur. J. Immunol. 29, 2082-2086.
144. Schäble, K., Thiebe, R., Flügel, A., Meindl, A., and Zachau, H. (1994). The human immunoglobulin kappa locus: pseudogenes, unique and repetitive sequences. Biol. Chem. Hoppe Seyler. 375, 189-199.
145. Schroeder, H. W Jr. (2006). Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev. Comp. Immunol. 30, 119-135.
146. Schroeder, H. W Jr., Hillson, J. L., and Perlmutter, R. M. (1987). Early restriction of the human antibody repertoire. Science 238, 791-793.
147. Schroeder, H. W Jr., Hillson, J. L., and Perlmutter, R. M. (1990). Structure and evolution of mammalian VH families. Int. Immunol. 2, 41-50.
148. Schroeder, H. W. Jr., Ippolito, G. C., and Shiokawa, S. (1998). Regulation of the antibody repertoire through control of HCDR3 diversity. Vaccine 16, 1383-1390.
149. Schroeder, H. W. Jr., Mortari, F., Shiokawa, S., Kirkham, P. M., Elgavish, R. A., and Bertrand, E E. 3rd. (1995). Developmental regulation of the human antibody repertoire. Ann. N.Y. Acad. Sci. 764, 242-260.
150. Shi, L., Wheeler, J. C., Sweet, R. W., Lu, J., Luo, J., Tornetta, M., et al. (2010). De novo selection of high-affinity antibodies from synthetic fab libraries displayed on phage as pIX fusion proteins. J. Mol. Biol. 397,385-396.
151. Shirai, H., Kidera, A., and Nakamura, H. (1996). Structural classification of CDR-H3 in antibodies. FEBS Lett. 399, 1-8.
152. Sidhu, S. S., and Fellouse, F. A. (2006). Synthetic therapeutic antibodies. Nat. Chem. Biol. 2, 682-688.
153. Sidhu, S. S., Li, B., Chen, Y., Fellouse, F. A., Eigenbrot, C., and Fuh, G. (2004). Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions. J. Mol. Biol. 338, 299-310.
154. Silacci, M., Brack, S. S., Spath, N., Buck, A., Hillinger, S., Arni, S., et al. (2006). Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng. Des. Sel. 19, 471-478.
155. Silacci, M., Brack, S., Schirru, G., Marlind, J., Ettorre, A., Merlo, A., et al. (2005). Design, construction, and characterization of a large synthetic human antibody phage display library. Proteomics 5, 2340-2350.
156. Sinclair, M. C., Gilchrist, J., and Aitken, R. (1997). Bovine IgG repertoire is dominated by a single diversified VH gene family. J. Immunol. 159, 3883-3889.
157. Smith, G. P. (1985). Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1317.
158. Stanfield, R. L., Dooley, H., Flajnik, M. E, and Wilson, I. A. (2004). Crystal structure of a shark single-domain antibody V region in complex with lysozyme. Science 305, 1770-1773.
159. Stanfield, R. L., Dooley, H., Verdino, P., Flajnik, M. F., and Wilson, I. A. (2007). Maturation of shark single-domain (IgNAR) antibodies: evidence for induced-fit binding. J. Mol. Biol. 367, 358-372.
160. Stanfield, R. L., and Wilson, I. A. (2010). "Antibody molecular structure," in Therapeutic Monoclonal Antibodies: From Bench to Clinic, ed Z. An (John Wiley and Sons, Inc.), 51-66.
161. Stephens, S., Emtage, S., Vetterlein, O., Chaplin, L., Bebbington, C., Nesbitt, A., et al. (1995). Comprehensive pharmacokinetics of a humanized antibody and analysis of residual anti-idiotypic responses. Immunology 85, 668-674.
162. Thiebe, R., Schäble, K., Bensch, A., Brensing-Küppers, J., Heim, V., Kirschbaum, T., et al. (1999). The variable genes and gene families of the mouse immunoglobulin kappa locus. Eur. J. Immunol. 29, 2072-2081.
163. Tomlinson, I. M., Cox, J. P., Herardi, G. E., Lesk, A. M., and Chothia, C. (1995). The structural repertoire of the human V kappa domain. EMBO J. 14, 4628-4638.
164. Tomlinson, I. M., Walter, G., Jones, P. T., Dear, P. H., Sonnhammer, E. L., Winter, G. (1996). The imprint of somatic hypermutation on the repertoire of human germline V genes. J. Mol. Biol. 256, 813-817.
165. Tomlinson, I. M., Walter, G., Marks, J. D., Llewelyn, M. B., and Winter, G. (1992). The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227, 776-798.
166. Tonegawa, S. (1983). Somatic generation of antibody diversity. Nature 14,575-581.
167. Tsurushita, N., Park, M., Pakabunto, K., Ong, K., Avdalovic, A., Fu, H., et al. (2004). Humanization of a chicken anti-IL-12 monoclonal antibody. J. Immunol. Methods 295, 9-19.
168. Vandenbroucke, K., de Haard, H., Beirnaert, E., Dreier, T., Lauwereys, M., Huyck, L., et al. (2010). Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis. Mucosal Immunol. 3, 49-56.
169. Vargas-Madrazo, E., Lara-Ochoa, E, and Almagro, J. C. (1995). Canonical structure repertoire of the antigen-binding site of immunoglobulins suggests strong geometrical restrictions associated to the mechanism of immune recognition. J. Mol. Biol. 254, 497-504.
170. Virnekas, B., Ge, L., Pluckthun, A., Schneider, K. C., Wellnhofer, G., and Moroney, S. E. (1994). Trinucleotide phosphoramidites: ideal reagents for the synthesis of mixed oligonucleotides for random mutagenesis. Nucleic Acids Res. 22, 5600-5607.
171. Viti, F., Nilsson, F., Demartis, S., Huber, A., and Neri, D. (2000). Design and use of phage display libraries for the selection of antibodies and enzymes. Meth. Enzymol. 326, 480-505.
172. Weill, J. C., and Reynaud, C. A. (1992). Early B-cell development in chickens, sheep and rabbits. Curr. Opin. Immunol. 4, 177-180.
173. Weinstein, J., Jiang, N., White, R. R., Fisher, D., and Quake, S. (2009). High-throughput sequencing of the zebrafish antibody repertoire. Science 324, 807-810.
174. Wesolowski, J., Alzogaray, V., Reyelt, J., Unger, M., Juarez, K., Urrutia, M., et al. (2009). Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med. Microbiol. Immunol. 198, 157-174.
175. Williams, A., and Barclay, A. (1988). The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 6, 381-405.
176. Wilson, I. A., and Stanfield, R. L. (1994). Antibody-antigen interactions: new structures and new con-formational changes. Curr. Opin. Struct. Biol. 4, 857-867.
177. Wilson, P. C., Bouteiller, O. D., Liu, Y.-J., Potter, K., Banchereau, J., Capra, J. D., et al. (1998). Somatic hypermutation introduces insertions and deletions into immunoglobulin V genes. J. Exp. Med. 187, 59-70.
178. Wong, S. E., Sellers, B. D., and Jacobson, M. P. (2011). Effects of somatic mutations on CDR loop flexibility during affinity maturation. Proteins 79, 821-829.
179. Wu, L., Oficjalska, K., Lambert, M., Fennell, B. J., Darmanin-Sheehan, A., Ni Shuilleabhain, D., et al. (2011). Fundamental characteristics of the immunoglobulin VH repertoire of chickens in comparison with those of humans, mice, and camelids.J. Immunol. 188, 322-333.
180. Wu, T., Johnson, G., and Kabat, E. (1993). Length distribution of CDRH3 in antibodies. Proteins 16, 1-7.
181. Wu, T. T., and Kabat, E. A. (1970). An analysis of the sequences of the variable regions of Bence Jones proteins and myeloma light chains and their implications for antibody complementarity. J. Exp. Med. 132, 211-250.
182. Yamanaka, H. I., Inoue, T., and Ikeda-Tanaka, O. (1996). Chicken monoclonal antibody isolated by a phage display system. J. Immunol. 157, 1156-1162.
183. Zemlin, M., Klinger, M., Link, J., Zemlin, C., Bauer, K., Engler, J. A., et al. (2003). Expressed murine and human CDR-H3 intervals of equal length exhibit distinct repertoires that differ in their amino acid composition and predicted range of structures. J. Mol. Biol. 334, 733-749.
184. Zhai, W., Glanville, J., Fuhrmann, M., Mei, L., Ni, I., Sundar, P. D., et al. (2011). Synthetic antibodies designed on natural sequence landscapes. J. Mol. Biol. 412, 55-71.
185. Zhao, S., and Lu, J. (2010). A germline knowledge based computational approach for determining antibody complementarity determining regions. Mol. Immunol. 47, 694-700.
186. Zhu, D., Lossos, C., Chapman-Fredricks, J., Matthews, J., Ikpatt, O., Ruiz, P., et al. (2011). Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas. PLoS ONE 6:e29114. doi: 10.1371/journal. pone.0029114